Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans

Author： Yamada I.   Fujino H.   Shimada S.   Kojima J.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.33, Iss.7, 2003-07, pp. : 789-803

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization

By Fujino H.   Yamada I.   Shimada S.   Yoneda M.   Kojima J.  

Xenobiotica, Vol. 33, Iss. 1, 2003-01 ,pp. : 27-41

Informa Healthcare

Access to resources Recommend Favorite

CYP2C76-mediated species difference in drug metabolism: A comparison of pitavastatin metabolism between monkeys and humans

By Uno Y.   Kumano T.   Kito G.   Nagata R.   Kamataki T.   Fujino H.  

Xenobiotica, Vol. 37, Iss. 1, 2007-01 ,pp. : 30-43

Informa Healthcare

Access to resources Recommend Favorite

Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors

By Fujino H.   Saito T.   Tsunenari Y.   Kojima J.   Sakaeda T.  

Xenobiotica, Vol. 34, Iss. 11-12, 2004-11 ,pp. : 961-971

Informa Healthcare

Access to resources Recommend Favorite

Cytoprotective and Antiproliferative Effects of HMG-CoA Reductase Inhibitors

By  

Current Enzyme Inhibition, Vol. 2, Iss. 3, 2006-08 ,pp. : 261-280

Bentham Science Publishers

Access to resources Recommend Favorite

The biology of HMG-CoA reductase: the pros of contra-regulation

By Hampton R.   Dimster-Denk D.   Rine J.  

Trends in Biochemical Sciences, Vol. 21, Iss. 4, 1996-04 ,pp. : 140-145

Elsevier

Access to resources Recommend Favorite